Toshinori Nakayama

Chiba University — Japan

Immunology and Microbiology · Life Sciences

97h-index33.6kcitations688works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(269), T-cell and B-cell Immunology(175), Immunotherapy and Immune Responses(89), IL-33, ST2, and ILC Pathways(79), Asthma and respiratory diseases(69)

Publications685 total

Table S1 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Table S3 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Table S2 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8<sup>+</sup> T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunity
Science Immunology·2025· 1 cited
O13-4 HER2CLIMB-03: phase 2 study of tucatinib with trastuzumab and capecitabine in previously treated HER2+ LA/MBC
Annals of Oncology·2025· 1 cited
182PAutomatic calculation of muscle volume of leg CT images, using artificial intelligence
Neuromuscular Disorders·2025
Increased expression of the <scp>PIEZO2</scp> mechanoreceptor in fibroblasts and endothelial cells within the lymphatic and vascular vessels of keloids
The Journal of Pathology·2025· 2 citedOpen Access
Author response: C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
2025Open Access
C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
2025Open Access
SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity
International Immunology·2025· 1 citedOpen Access
C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice
eLife·2024· 1 citedOpen Access
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
page 1 of 35Next →

Frequent Co-authors

Masaru Taniguchi(25), Shinichiro Motohashi(9), Mitchell Kronenberg(7), Tetsu Kawano(6), Masakatsu Yamashita(6), Damon J. Tumes(6), Yasuhiko Koezuka(5), Michishige Harada(5), Kiyoshi Hirahara(5), Yusuke Endo(5), Kenta Shinoda(5), Yoshitaka Okamoto(5), Hiroyuki Hosokawa(4), Takehiko Fujisawa(4), Atsushi Onodera(4), Luc Van Kaer(4), Yasunori Akutsu(4), Koutaro Yokote(3), Isao Toura(3), Haruhiko Koseki(3)